IDT Biologika as a Contract Development and Manufacturing Organization
Products
Information
IDT Biologika is an international leader in the contract development and manufacturing of biologics. The company focuses on the customized development and manufacturing of viral vaccines (phases I, II, III), gene therapeutics, immunotherapeutics, oncolytic viruses as well as sterile liquid and lyophilized biologics to improve human health worldwide. We offer clients seamless end-to-end solutions and the ability to nimbly scale projects from development and pre-clinical through large scale production and packaging. Our fully integrated services are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP (and up to BLS2) manufacturing capabilities meeting EMA, FDA and ANVISA standards. Contact us for more information.
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
GermanyUnited States
All categories
Sera and VaccinesBiopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)Custom Manufacturing (general category)Cell & Gene therapyInnovative APIsProductsServices
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)
